Nahal Rose Lalefar MD
Assistant Professor, Department of Pediatrics, UCSF Benioff Children's Hospital Oakland
Join to View Full Profile
747 52nd StOakland, CA 94609
Phone+1 510-428-3885
Fax+1 510-597-7199
Dr. Lalefar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Nahal Lalefar is a Pediatric Hematology and Oncology specialist based in Oakland, CA. She completed her medical education and residency in Pediatrics at the University of California, before undertaking a fellowship in Pediatric Hematology/Oncology at the Children's Hospital in Oakland.
Education & Training
UCSF Benioff Children’s Hospital OaklandFellowship, Pediatric Hematology/Oncology, 2012 - 2015
University of California (San Francisco)/FresnoResidency, Pediatrics, 2008 - 2011
University of California, Davis, School of MedicineClass of 2008
Certifications & Licensure
CA State Medical License 2010 - 2025
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- A Trial Comparing Unrelated Donor BMT with IST for Pediatric and Young Adult Patients with Severe Aplastic Anemia (TransIT, BMT CTN 2202) Start of enrollment: 2023 Jan 25
Roles: Contact
Publications & Presentations
PubMed
- High Melphalan Exposure Increases the Risk of Graft-versus-Host Disease in Pediatric Patients Undergoing Alpha-Beta T-Cell Depleted Haploidentical Transplantation.Christopher C Dvorak, Soohee Cho, Gabriel Salinas Cisneros, Christine S Higham, Julia Chu
Transplantation and Cellular Therapy. 2025-04-02 - The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated Toxicities.Takuto Takahashi, Benjamin Watkins, Brandi Bratrude, Donna Neuberg, Kyle Hebert
Transplantation and Cellular Therapy. 2025-02-01 - 1 citationsEffect of rabbit ATG PK on outcomes after TCR-αβ/CD19-depleted pediatric haploidentical HCT for hematologic malignancy.Christopher C Dvorak, Janel R Long-Boyle, Lucia Holbrook-Brown, Hisham Abdel-Azim, Alice Bertaina
Blood Advances. 2024-12-10
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
